Evidence map›Paper›PMID 40959688›Full record

ReviewPostepy psychiatrii neurologii2025

Attention-deficit/hyperactivity disorder: insights, advances and challenges in research and practice.

Siva Prasad, Rahul Kumminimana

Abstract readReview
In one paragraph

Review in Postepy psychiatrii neurologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Siva PrasadInstitute for Communicative and Cognitive Neurosciences (ICCONS), Shoranur, Kerala, India.
Rahul KumminimanaInstitute for Communicative and Cognitive Neurosciences (ICCONS), Shoranur, Kerala, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This review mainly focuses on the aetiology of attention-deficit/hyperactivity disorder (ADHD) including genetic, neuro-biological, biochemical and environmental factors. It also emphasizes the possible management of the disorder. This knowledge will be essential for developing therapeutic interventions and prevention measures. Views: ADHD is a neurodevelopmental psychiatric disorder, characterized by pervasive patterns of inattention, hyperactivity, or impulsivity. Globally, it affects up to 7-10% of elementary school children, and symptoms frequently persist into adulthood. Among adults, 2-5% experience ADHD symptoms worldwide. The aetiology and developmental trajectory of the disorder remain unknown. ADHD is caused by a combination of genetic, psychological, physiological, biochemical, and environmental factors. All of these factors are thought to permanently change the development of the dopaminergic and noradrenergic system, which is a fundamental neurobiological mechanism behind the disorder. Conclusions: Untreated ADHD can have long-term effects on individuals throughout their lifetime and cause adverse life trajectories such as poor educational and occupational outcomes, substance addiction, accidents, suicide, criminal activity, and co-occurring mental and physical health disorders. Principal management options include psychopharmacological treatments such as group cognitive behavioural therapy and social skills training, parent education programmes, and school-based initiatives, as well as medication employing stimulants and non-stimulants.

Indexed as

ADHDbehavioural therapyenvironmental factorsepigeneticsneurobiology

Identifiers

PMID40959688
PMCPMC12435561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.